"Lenvat" (lenvatinib) is an antitumor drug used to treat certain types of cancer.

Indications: thyroid cancer, liver cancer, kidney cancer, and endometrial cancer.

Principle of action: it blocks proteins that promote the growth and spread of cancer cells, reducing the size of the tumor.

The dosage is determined by the doctor based on the patient's condition.

Side effects: fatigue, increased blood pressure, nausea, and diarrhea.

Contraindications: hypersensitivity, pregnancy and lactation, age under 18, and severe chronic kidney diseases.